Video

Talking About Tardive Dyskinesia with Dr. Stanley Caroff: Part 2

Author(s):

Lisa Neuman
Conference|American Psychiatric Association

Dr. Stanley Caroff, Emeritus Professor CE of Psychiatry at the Philadelphia VA Medical Center, sits down with MD Magazine to explain what tardive dyskinesia is, and why it's so important for psychiatrists to be aware of this side effect in their patients taking antipsychotic medications. This is the conclusion of a two-part conversation.

Related Videos
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
Related Content
Katherine R. Tuttle, MD, Clinical Professor of Medicine, University of Washington Medicine, and Executive Director for Research, Providence Health Care, and Regional Co-Principal Investigator, Institute of Translational Health Sciences, Providence Medical Research Center
October 26th 2024

Semaglutide Shows Benefit in CKD and Type 2 Diabetes Across Kidney Disease Severities

Victoria Johnson
Default thumbnail for Medical Ethics Unpacked
October 17th 2024

Introducing Medical Ethics Unpacked, with Dominic Sisti, PhD, and Steve Levine, MD

Steve Levine, MD Dominic Sisti, PhD
Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis
October 26th 2024

Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis

Tim Smith
default thumbnail for Don't Miss a Beat podcast.
September 2nd 2024

Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Hiddo Heerspink, PharmD, PhD | Credit: George Institute for Global Health
October 25th 2024

Semaglutide Shows Promise, Reduces UACR in Nondiabetic Kidney Disease

Patrick Campbell
New Phase 3b Findings Suggest Lebrikizumab Improved Skin, Itch for Atopic Dermatitis
October 25th 2024

New Phase 3b Findings Suggest Lebrikizumab Improved Skin, Itch for Atopic Dermatitis

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.